ABVC stock

ABVC Biopharma Inc (ABVC) financials · rev $796.0K

ABVC Biopharma Inc (ABVC) rev $796.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$296.0K$509.6K
Cost of Revenue$0$763
Gross Profit$0$508.8K
Operating Income-$7.2M-$4.7M
Net Income-$7.9M-$4.9M
EPS (Diluted)$-0.39$-0.42
Cached annual balance sheet
LineFY2025FY2024
Total Assets$21.1M$7.5M
Current Assets$2.5M$2.2M
Cash & Equivalents$681.5K$248.4K
Inventory$0$0
PP&E$12.8M$511.1K
Total Liabilities$7.8M$6.8M
Current Liabilities$6.2M$6.6M
Short-term Debt$755.5K$840.3K
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity$11.1M$1.2M
Retained Earnings-$76.9M-$68.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$3.0M-$1.8M
CapEx$0$0
Investing Cash Flow-$1.2M$0
Financing Cash Flow$4.6M$2.0M
Dividends Paid$0$0
Net Change in Cash$463.2K$0
Free Cash Flow$0$0

FAQ

What is ABVC P/E and revenue?

ABVC Biopharma Inc (ABVC) rev $796.0K.

What is ABVC revenue?

ABVC Biopharma Inc last cached revenue is $296.0K (FY2025).

Is ABVC profitable?

ABVC Biopharma Inc last cached net income is -$7.9M.

What are ABVC total assets?

ABVC Biopharma Inc last cached total assets are $21.1M.

What is ABVC free cash flow?

ABVC Biopharma Inc last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.